Cargando…
A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort
OBJECTIVE: To prospectively investigate associations of presurgical body mass index (BMI) with clinicopathological factors and its prognostic significance in radically D2-resected patients with non-metastasized gastric cancer (GC) and Siewert type II/III adenocarcinoma of esophagogastric junction (A...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620246/ https://www.ncbi.nlm.nih.gov/pubmed/28978106 http://dx.doi.org/10.18632/oncotarget.19251 |
_version_ | 1783267546338689024 |
---|---|
author | Huang, Lei Wei, Zhi-Jian Li, Tuan-Jie Jiang, Yu-Ming Xu, A-Man |
author_facet | Huang, Lei Wei, Zhi-Jian Li, Tuan-Jie Jiang, Yu-Ming Xu, A-Man |
author_sort | Huang, Lei |
collection | PubMed |
description | OBJECTIVE: To prospectively investigate associations of presurgical body mass index (BMI) with clinicopathological factors and its prognostic significance in radically D2-resected patients with non-metastasized gastric cancer (GC) and Siewert type II/III adenocarcinoma of esophagogastric junction (AEG). METHODS: A large prospective cohort consisting of radically-resected GC and AEG patients was analyzed. Follow-up was successful in 671 out of 700 patients, who were categorized into underweight (BMI<18.5), normal-weight (BMI=18.5-22.9), overweight (BMI=23-24.9), and obese (BMI≥25) groups according to Asian standards. BMI-associated factors were explored using multivariable logistic regression with adjustment. Cancer-specific survival analyses were conducted applying both univariable and multivariable Cox regression methods. RESULTS: Pre-operation, higher hemoglobin levels and smaller anemia proportions were observed in larger BMI groups. Higher BMI tended to be associated with higher neutrophil-lymphocyte ratios (NLRs). Patients with higher BMI had smaller tumors and more often stage I tumors, but longer surgical time and postsurgical stay. In multivariable analyses, higher hemoglobin levels, upper tumor location, poorer differentiation, and higher NLR were significantly associated with higher BMI. Overall, survival analyses revealed no significant role of BMI. However, in further stratifications after adjustment, compared to patients with normal BMI, obese patients had better survival in women, but worse in those with AEG; underweight was associated with reduced mortality risk in tumors differentiated well to moderately; overweight patients had increased death hazard when having thrombocytopenia. CONCLUSION: Overall, preoperative BMI had limited prognostic significance in operated GC patients. However, under specific conditions (e.g., female, AEG, good differentiation, and thrombocytopenia), BMI might indicate postoperative survival. |
format | Online Article Text |
id | pubmed-5620246 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-56202462017-10-03 A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort Huang, Lei Wei, Zhi-Jian Li, Tuan-Jie Jiang, Yu-Ming Xu, A-Man Oncotarget Research Paper OBJECTIVE: To prospectively investigate associations of presurgical body mass index (BMI) with clinicopathological factors and its prognostic significance in radically D2-resected patients with non-metastasized gastric cancer (GC) and Siewert type II/III adenocarcinoma of esophagogastric junction (AEG). METHODS: A large prospective cohort consisting of radically-resected GC and AEG patients was analyzed. Follow-up was successful in 671 out of 700 patients, who were categorized into underweight (BMI<18.5), normal-weight (BMI=18.5-22.9), overweight (BMI=23-24.9), and obese (BMI≥25) groups according to Asian standards. BMI-associated factors were explored using multivariable logistic regression with adjustment. Cancer-specific survival analyses were conducted applying both univariable and multivariable Cox regression methods. RESULTS: Pre-operation, higher hemoglobin levels and smaller anemia proportions were observed in larger BMI groups. Higher BMI tended to be associated with higher neutrophil-lymphocyte ratios (NLRs). Patients with higher BMI had smaller tumors and more often stage I tumors, but longer surgical time and postsurgical stay. In multivariable analyses, higher hemoglobin levels, upper tumor location, poorer differentiation, and higher NLR were significantly associated with higher BMI. Overall, survival analyses revealed no significant role of BMI. However, in further stratifications after adjustment, compared to patients with normal BMI, obese patients had better survival in women, but worse in those with AEG; underweight was associated with reduced mortality risk in tumors differentiated well to moderately; overweight patients had increased death hazard when having thrombocytopenia. CONCLUSION: Overall, preoperative BMI had limited prognostic significance in operated GC patients. However, under specific conditions (e.g., female, AEG, good differentiation, and thrombocytopenia), BMI might indicate postoperative survival. Impact Journals LLC 2017-07-12 /pmc/articles/PMC5620246/ /pubmed/28978106 http://dx.doi.org/10.18632/oncotarget.19251 Text en Copyright: © 2017 Huang et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Research Paper Huang, Lei Wei, Zhi-Jian Li, Tuan-Jie Jiang, Yu-Ming Xu, A-Man A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort |
title | A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort |
title_full | A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort |
title_fullStr | A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort |
title_full_unstemmed | A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort |
title_short | A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort |
title_sort | prospective appraisal of preoperative body mass index in d2-resected patients with non-metastatic gastric carcinoma and siewert type ii/iii adenocarcinoma of esophagogastric junction: results from a large-scale cohort |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620246/ https://www.ncbi.nlm.nih.gov/pubmed/28978106 http://dx.doi.org/10.18632/oncotarget.19251 |
work_keys_str_mv | AT huanglei aprospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort AT weizhijian aprospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort AT lituanjie aprospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort AT jiangyuming aprospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort AT xuaman aprospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort AT huanglei prospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort AT weizhijian prospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort AT lituanjie prospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort AT jiangyuming prospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort AT xuaman prospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort |